JP2009503079A5 - - Google Patents

Download PDF

Info

Publication number
JP2009503079A5
JP2009503079A5 JP2008525065A JP2008525065A JP2009503079A5 JP 2009503079 A5 JP2009503079 A5 JP 2009503079A5 JP 2008525065 A JP2008525065 A JP 2008525065A JP 2008525065 A JP2008525065 A JP 2008525065A JP 2009503079 A5 JP2009503079 A5 JP 2009503079A5
Authority
JP
Japan
Prior art keywords
compound
iridium
previously shown
ligand
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008525065A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009503079A (ja
JP5507081B2 (ja
Filing date
Publication date
Priority claimed from US11/194,280 external-priority patent/US7528267B2/en
Application filed filed Critical
Publication of JP2009503079A publication Critical patent/JP2009503079A/ja
Publication of JP2009503079A5 publication Critical patent/JP2009503079A5/ja
Application granted granted Critical
Publication of JP5507081B2 publication Critical patent/JP5507081B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008525065A 2005-08-01 2006-08-01 クロメンをエナンチオ選択的に水素化する方法 Expired - Fee Related JP5507081B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/194,280 US7528267B2 (en) 2005-08-01 2005-08-01 Method for enantioselective hydrogenation of chromenes
US11/194,280 2005-08-01
PCT/US2006/029589 WO2007016423A2 (en) 2005-08-01 2006-08-01 Method for enantioselective hydrogenation of chromenes

Publications (3)

Publication Number Publication Date
JP2009503079A JP2009503079A (ja) 2009-01-29
JP2009503079A5 true JP2009503079A5 (https=) 2009-04-23
JP5507081B2 JP5507081B2 (ja) 2014-05-28

Family

ID=37695254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008525065A Expired - Fee Related JP5507081B2 (ja) 2005-08-01 2006-08-01 クロメンをエナンチオ選択的に水素化する方法

Country Status (8)

Country Link
US (4) US7528267B2 (https=)
EP (1) EP1919887B1 (https=)
JP (1) JP5507081B2 (https=)
CN (3) CN103755675B (https=)
AU (1) AU2006275587B2 (https=)
CA (1) CA2617665C (https=)
DK (1) DK1919887T3 (https=)
WO (1) WO2007016423A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2504682A1 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
GB0610804D0 (en) * 2006-05-31 2006-07-12 Portela & Ca Sa New crystal forms
US7714348B2 (en) * 2006-10-06 2010-05-11 Ac-Led Lighting, L.L.C. AC/DC light emitting diodes with integrated protection mechanism
WO2008153158A1 (ja) * 2007-06-13 2008-12-18 Otsuka Pharmaceutical Co., Ltd. エクオール含有抽出物及びその製造方法、エクオール抽出方法、並びにエクオールを含む食品
EP2231648A1 (en) * 2007-12-05 2010-09-29 BIAL - Portela & Ca., S.A. New salts and crystal forms
EP2133080A1 (de) 2008-06-13 2009-12-16 Haelan Schweiz GmbH Zusammensetzungen enthaltend Equol
RU2364442C1 (ru) * 2008-06-30 2009-08-20 Государственное образовательное учреждение высшего профессионального образования "Тверской государственный технический университет" Способ приготовления модифицированного платинового катализатора для энантиоселективного гидрирования сложных эфиров альфа-кетокарбоновых кислот
EP2154133A1 (de) 2008-08-14 2010-02-17 System Biologie AG Synthese von Equol
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
US7875736B2 (en) * 2009-05-19 2011-01-25 Kaohsiung Medical University Intermediate compounds and processes for the preparation of 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran
US7875735B2 (en) * 2009-05-19 2011-01-25 Kaohsiung Medical University Processes for preparing isoflavonoids using 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran as a starting material
WO2011034126A1 (ja) * 2009-09-18 2011-03-24 不二製油株式会社 エクオールの不斉合成法
CN102633763B (zh) * 2012-04-11 2014-02-26 黑龙江大学 一种(s)-雌马酚的制备方法
WO2015117202A1 (en) 2014-02-07 2015-08-13 Novogen Limited Functionalised benzopyran compounds and use thereof
JP6744860B2 (ja) * 2014-09-10 2020-08-19 システム バイオロジー アーゲー イソフラバンおよびその中間体の合成
JP2017531025A (ja) * 2014-10-14 2017-10-19 ジャクソン，リチャード・エル Ｓ−エクオールの無水結晶形
US10391079B2 (en) 2016-07-26 2019-08-27 Ausio Pharmaceuticals, Llc Methods of diagnosing and treating Alzheimer's disease with S-equol
AU2019285640A1 (en) 2018-06-15 2021-01-21 Board Of Regents Of The University Of Texas System Methods of treating and preventing breast cancer with S-equol
WO2019240872A1 (en) 2018-06-15 2019-12-19 The Board Of Regents Of The University Of Texas System Methods of treating and preventing melanoma with s-equol
WO2020071818A1 (ko) * 2018-10-02 2020-04-09 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매
KR102819124B1 (ko) * 2018-10-02 2025-06-12 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264509A (en) * 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
KR20000057548A (ko) * 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
DE69833365T2 (de) * 1997-03-06 2006-09-28 Mitsui Chemicals, Inc. Verfahren zur herstellung optisch aktiver amine
AUPP868599A0 (en) * 1999-02-15 1999-03-11 Novogen Research Pty Ltd Production of isoflavone derivatives
US6576772B1 (en) * 1999-11-10 2003-06-10 The Penn State Research Foundation Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions
SE9904850D0 (sv) * 1999-12-30 1999-12-30 Pharmacia & Upjohn Ab Novel process and intermediates
DE10044091A1 (de) * 2000-09-07 2002-04-04 Merck Patent Gmbh Chromanonderivate
ATE294806T1 (de) * 2000-09-21 2005-05-15 Solvias Ag Phosphinite-oxazoline und metallkomplexe
WO2003023056A2 (en) 2001-09-12 2003-03-20 F. Hoffmann-La Roche Ag Specific markers for multiple sclerosis
EP1545206B1 (en) * 2002-07-24 2020-03-04 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
DE10237648A1 (de) 2002-08-13 2004-02-26 Behr Gmbh & Co. Wärmeübertrager
CA2504682A1 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
AU2002952453A0 (en) 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
PL377427A1 (pl) * 2002-12-19 2006-02-06 Pharmacia Corporation Sposoby i kompozycje do leczenia infekcji wirusem opryszczki z zastosowaniem inhibitorów selektywnych względem cyklooksygenazy-2 lub inhibitorów cyklooksygenazy-2 w połączeniu ze środkami przeciwwirusowymi
ITMI20031354A1 (it) 2003-07-02 2005-01-03 Istituto Di Chimica Biomolecolare D El Cnr Sezione Sintesis enantioselettiva di composti enantiomericamente arricchiti.

Similar Documents

Publication Publication Date Title
JP2009503079A5 (https=)
DE60311305D1 (de) Bidentate c,p chirale phosphan-liganden
NO20052993D0 (no) 4,5-diaryltiazolderivater som CB-1 ligander.
AP2005003368A0 (en) PyrazoloÄ1,5-AÜÄ1,3,5Ütriazine derivatives as cannabinoid receptor ligands.
WO2006058700A8 (en) Acetamide compounds as fungicides
SG126757A1 (en) Organometallic compounds
AU2003237686A1 (en) Rna interference mediating small rna molecules
IL191711A0 (en) 1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as ptp-as inhibitors
JP2008518885A5 (https=)
EP1859656A4 (en) ORGANOMETALLIC COMPLEXES
AU2003274053A1 (en) Aryloxyalkylamine derivates as h3 receptor ligands
JP2005515295A5 (https=)
WO2004020969A3 (en) Production of nanoparticles having a defined number of ligands
JP2006339594A5 (https=)
EP1834363A4 (en) ORGANOMETALLIC COMPLEXES
WO2005007635A3 (en) Combretastatin derivatives with cytotoxic action
WO2006100169A3 (en) Unsymmetrically substituted phospholane catalysts
JP2004269491A5 (https=)
AU2003225962A1 (en) Phosphinometallocenylamides as novel ligands for asymmetric catalysis
NL1030010A1 (nl) 4-Amino-gesubstitueerde-2-gesubstitueerde-1,2,3,4- tetrahydrochinolineverbindingen.
TWI346098B (en) Linker compound, ligand complex and production method thereof
AP2007004174A0 (en) Substituted aryl 1,4-pyrazine derivatives
WO2004089920A3 (de) Amin-substituierte diphenyldiphosphine und deren verwendung in metallkomplexen für asymmetrische synthesen
AU2003252411A1 (en) Multipurpose linker compounds and ligands and process for producing the same
AU2003292698A1 (en) PROCESS FOR PRODUCING Alpha,ss-UNSATURATED CARBONYL COMPOUND